Vicapsys Life Sciences, Inc. (VICP): auditor change — Vicapsys Life Sciences dismisses auditor D. Brooks and appoints Assurance Dimensions

Vicapsys Life Sciences, Inc.

Board dismissed D. Brooks and Associates CPAs as independent auditor effective May 12, 2023.
Prior audit reports for FY2022 and FY2021 included a going-concern explanatory paragraph but no adverse opinions.
No disagreements or reportable events occurred during the two most recent fiscal years or interim period.
Board appointed Assurance Dimensions as new independent registered public accounting firm on May 12, 2023.
D. Brooks furnished a letter to the SEC, dated May 17, 2023, agreeing with the disclosure.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Vicapsys Life Sciences, Inc. engaged Assurance Dimensions as its auditor.

Action: engagement
Auditor: Assurance Dimensions

Exact text from the filing

the Board appointed Assurance Dimensions. (“Assurance”) as the Company’s independent registered public accounting firm to audit the Company’s consolidated financial statements for the fiscal year ending December 31, 2023.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Vicapsys Life Sciences, Inc. dismissed D. Brooks and Associates CPAs, P.A. as its auditor.

Action: dismissal
Auditor: D. Brooks and Associates CPAs, P.A.

Exact text from the filing

the Board of Directors (the “Board”) of the Vicapsys Life Sciences, Inc. (the “Company”) approved the dismissal of D. Brooks and Associates CPAs, P.A. (“D. Brooks”) as the Company’s independent registered public accounting firm effective May 12, 2023.

View on SEC.gov

Browse all auditor changes →

Vicapsys Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-017970

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.